Consider This Before Taking a Position in Blue Bird (BLBD)

Shares of Small-cap consumer discretionary company Blue Bird moved 6.3% this afternoon, and are now trading at $21.79 per share. The average analyst target price for the stock is $29.67.

Blue Bird Corporation designs, engineers, manufactures, and sells school buses and related parts in the United States, Canada, and internationally.

Based on its trailing earning per share of -1.07, Blue Bird has a trailing 12 month Price to Earnings (P/E) ratio of -20.4 BLBD has a forward P/E ratio of 15.3.

The company has a price to earnings growth (PEG) ratio of 1.5. A number between 0 and 1 could mean that the market is undervaluing Blue Bird's estimated growth potential

The Company's Revenues Are Declining

2019-09-30 2020-09-30 2021-09-30 2022-09-30
Revenue (k) $1,018,874 $879,221 $683,995 $800,637
Gross Margins 13.1% 10.9% 10.6% 4.6%
Operating Margins 4.3% 2.5% 1.0% -5.1%
Net Margins 2.38% 1.39% -0.04% -5.72%
Net Income (k) $24,300 $12,185 -$289 -$45,759
Net Interest Expense (k) -$12,870 -$12,241 -$9,678 -$14,666
Depreciation & Amort. (k) -$10,383 -$14,400 -$13,446 -$14,050
Earnings Per Share $0.9 $0.45 -$0.01 -$1.07
EPS Growth n/a -50.0% -102.22% -10600.0%
Diluted Shares (k) 27,044 27,087 27,139 32,093
Free Cash Flow (k) $20,192 -$15,509 -$66,453 -$30,890
Capital Expenditures -$35,514 -$18,968 -$12,212 -$6,453
Net Current Assets (k) -$261,133 -$253,749 -$232,603 -$190,268
Current Ratio 1.01 1.05 1.25 1.06
Long Term Debt (k) $173,226 $164,204 $194,573 $150,390
LT Debt to Equity -2.55 -3.08 -5.96 108.82

Blue Bird has declining revenues and decreasing reinvestment in the business, slimmer gross margins than its peers, and weak operating margins with a negative growth trend. Additional warning signs include declining EPS growth, negative and highly variable cash flows, and high levels of debt. Blue Bird has just enough current assets to cover current liabilities.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS